Design, Synthesis, and Bioevaluation of Novel NLRP3 Inhibitor with IBD Immunotherapy from the Virtual ScreenZiwen Zhang, Xianfeng Gu, Kai Yin et al.|Journal of Medicinal Chemistry|2024Cited by 14